Souhaitez-vous accéder aux communiqués récents ?

Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients1 New findings from this investigational study build on the strength of the data for amivantamab in...

Dublin, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The "Effective Management of Supply Chain Risk Training Course (Oct 16th - Oct 17th, 2025)" has been added to ResearchAndMarkets.com's offering. "A...

Recommendation based on the findings from the Phase 3 ASTRO study in ulcerative colitis.1,2,3 Guselkumab has the potential to become the first IL-23 inhibitor to offer both subcutaneous and...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor.1 Filing based on four Phase 3 studies that met all primary and co-primary endpoints....

Chemotherapy-free combination regimen has the potential to usher in new era for first-line treatment, with median overall survival projected to exceed four years, surpassing monotherapy TKI...

New data demonstrate amivantamab combination significantly reduces common EGFR and MET resistance mutations seen with EGFR TKIs1 BEERSE, BELGIUM , Sept. 06, 2025 (GLOBE NEWSWIRE) -- Janssen-Cilag...

World’s #1 Selling Contact Lens Brand ACUVUE®1 Brings Pioneering Innovation For Astigmatic Patients, Providing Visual Clarity And Comfort+2 The First^^ Toric Lens to have an Optimised Design...

Dublin, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The "3D Printing Plastics Market by Type (Photopolymer, ABS, Polyamide, PLA, PETG), Form (Filament, Liquid, Powder), Application (Prototyping,...

The Estonian economy continues to grow slowly, with the latest forecasts estimating annual economic growth at 1.2%. The construction market is showing signs of stabilisation. Within the buildings...

Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "3D Printed Prosthetics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" has been added to ResearchAndMarkets.com's...